The speed of Covid-19 vaccine trials should inspire the pharmaceutical and medical device industries to accelerate its clinical testing, according to Shweta Maniar, Google Cloud’s director for healthcare and life sciences. She argued that harnessing real-world data will make faster clinical trials achievable for all therapeutics and devices, possibly even eliminating the need to recruit a placebo arm.
MedCity News is inviting all startups aiming to reinvent the clinical trials industry — that were founded in 2020 and earlier — to apply and take part in a pitch contest at our inaugural INVEST PharmaTech virtual event on July 26.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
The partners aim to make decentralized clinical trials more efficient and less expensive through greater use of AI and machine learning.
Expect more clinical trial sponsors to embrace these technologies as the industry sees wider adoption of decentralized clinical trials.
UBC partners with Seqster to leverage the latter's technology to allow patients to gather their own medical records for decentralized clinical trials. This could help speed up clinical trial enrollment.
ntegrated software, accessible genetic data, and advances in precision medicine can transform the lives of millions of patients–if the clinical trial and larger medical industry embrace these trends.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Medable recently raised $304 million, its fourth funding round in the past two years. The company’s software can be used to virtually consent patients into clinical trials and run telehealth visits as part of a trial.
This pandemic has shown that collaboration, biosimulation and decentralized trials, and active preparedness programs lead to fast, effective drug development when we really need it.
The pharmaceutical industry should be leading the development and implementation of decentralized clinical trials (DCTs) given their expertise in clinical research.
Digital health startups and pharma industry players sometimes don't speak the same language, and the culture gap has led to failures in the past. A new accelerator focused on helping digital health companies engage better with pharma hopes to flip the script.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Curebase, a startup building software for decentralized clinical trials, raised $15 million in funding. The startup ran six trials related to Covid-19 in the last year.
With the emergence of smart and connected devices and technologies, CROs and life sciences organizations are able to more easily perform decentralized, virtual clinical trials. Now, industry leaders are on a mission to make the practice of administering decentralized clinical trials the norm.
Now that trials can happen nearly anywhere, privacy teams and lawyers need to understand how data is collected, stored, managed, disseminated, and ultimately, archived or deleted.
Covid-19 showed that pharma companies can be nimble and implement changes that prevent processes from weighing down on operations. But which of these operational and strategic changes will stand the test of time and make this year and the future bright for the industry?
In a interview, an executive from Medable said patients will likely demand to have the choice of whether to show up at trial sites or participate in studies remotely. The Covid-19 pandemic has accelerated a trend toward decentralized trials that was already underway before it began.